🚀 VC round data is live in beta, check it out!
RaySearch Labs Valuation Multiples
Discover revenue and EBITDA valuation multiples for RaySearch Labs and similar public comparables like PHC Holdings, Innovita Biological Tech, Diagnósticos da América, Schrödinger and more.
RaySearch Labs Overview
About RaySearch Labs
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia Pacific, Europe and the rest of the world.
Founded
2000
HQ
Employees
416
Website
Financials (LTM)
EV
$852M
RaySearch Labs Financials
RaySearch Labs reported last 12-month revenue of $154M and EBITDA of $68M.
In the same LTM period, RaySearch Labs generated $142M in gross profit, $68M in EBITDA, and $27M in net income.
Revenue (LTM)
RaySearch Labs P&L
In the most recent fiscal year, RaySearch Labs reported revenue of $151M and EBITDA of $66M.
RaySearch Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $154M | XXX | $151M | XXX | XXX | XXX |
| Gross Profit | $142M | XXX | $136M | XXX | XXX | XXX |
| Gross Margin | 92% | XXX | 90% | XXX | XXX | XXX |
| EBITDA | $68M | XXX | $66M | XXX | XXX | XXX |
| EBITDA Margin | 44% | XXX | 43% | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $27M | XXX | $26M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 17% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
RaySearch Labs Stock Performance
RaySearch Labs has current market cap of $853M, and enterprise value of $852M.
Market Cap Evolution
RaySearch Labs' stock price is $24.89.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $852M | $853M | 0.3% | XXX | XXX | XXX | $0.75 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRaySearch Labs Valuation Multiples
RaySearch Labs trades at 5.5x EV/Revenue multiple, and 12.6x EV/EBITDA.
EV / Revenue (LTM)
RaySearch Labs Financial Valuation Multiples
As of April 20, 2026, RaySearch Labs has market cap of $853M and EV of $852M.
Equity research analysts estimate RaySearch Labs' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
RaySearch Labs has a P/E ratio of 31.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $853M | XXX | $853M | XXX | XXX | XXX |
| EV (current) | $852M | XXX | $852M | XXX | XXX | XXX |
| EV/Revenue | 5.5x | XXX | 5.6x | XXX | XXX | XXX |
| EV/EBITDA | 12.6x | XXX | 13.0x | XXX | XXX | XXX |
| EV/EBIT | 24.1x | XXX | 23.7x | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | 6.3x | XXX | XXX | XXX |
| P/E | 31.2x | XXX | 33.3x | XXX | XXX | XXX |
| EV/FCF | 56.4x | XXX | 49.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified RaySearch Labs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
RaySearch Labs Margins & Growth Rates
RaySearch Labs' revenue in the last 12 month grew by 7%.
RaySearch Labs' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
RaySearch Labs' rule of 40 is 55% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
RaySearch Labs' rule of X is 68% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
RaySearch Labs Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 44% | XXX | 43% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 55% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 68% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 27% | XXX | 27% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 21% | XXX | 21% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 20% | XXX | 20% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 66% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
RaySearch Labs Public Comps
See public comps and valuation multiples for other Healthcare Software and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| RaySearch Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| PHC Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Innovita Biological Tech | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnósticos da América | XXX | XXX | XXX | XXX | XXX | XXX |
| Schrödinger | XXX | XXX | XXX | XXX | XXX | XXX |
| Yidu Tech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
RaySearch Labs M&A Activity
RaySearch Labs acquired XXX companies to date.
Last acquisition by RaySearch Labs was on XXXXXXXX, XXXXX. RaySearch Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by RaySearch Labs
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRaySearch Labs Investment Activity
RaySearch Labs invested in XXX companies to date.
RaySearch Labs made its latest investment on XXXXXXXX, XXXXX. RaySearch Labs invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by RaySearch Labs
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout RaySearch Labs
| When was RaySearch Labs founded? | RaySearch Labs was founded in 2000. |
| Where is RaySearch Labs headquartered? | RaySearch Labs is headquartered in Sweden. |
| How many employees does RaySearch Labs have? | As of today, RaySearch Labs has over 416 employees. |
| Who is the CEO of RaySearch Labs? | RaySearch Labs' CEO is Johan Lof. |
| Is RaySearch Labs publicly listed? | Yes, RaySearch Labs is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of RaySearch Labs? | RaySearch Labs trades under RAY B ticker. |
| When did RaySearch Labs go public? | RaySearch Labs went public in 1991. |
| Who are competitors of RaySearch Labs? | RaySearch Labs main competitors are PHC Holdings, Innovita Biological Tech, Diagnósticos da América, Schrödinger. |
| What is the current market cap of RaySearch Labs? | RaySearch Labs' current market cap is $853M. |
| What is the current revenue of RaySearch Labs? | RaySearch Labs' last 12 months revenue is $154M. |
| What is the current revenue growth of RaySearch Labs? | RaySearch Labs revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of RaySearch Labs? | Current revenue multiple of RaySearch Labs is 5.5x. |
| Is RaySearch Labs profitable? | Yes, RaySearch Labs is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of RaySearch Labs? | RaySearch Labs' last 12 months EBITDA is $68M. |
| What is RaySearch Labs' EBITDA margin? | RaySearch Labs' last 12 months EBITDA margin is 44%. |
| What is the current EV/EBITDA multiple of RaySearch Labs? | Current EBITDA multiple of RaySearch Labs is 12.6x. |
| What is the current FCF of RaySearch Labs? | RaySearch Labs' last 12 months FCF is $15M. |
| What is RaySearch Labs' FCF margin? | RaySearch Labs' last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of RaySearch Labs? | Current FCF multiple of RaySearch Labs is 56.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.